Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
REV Group $9 billion merger with Terex
We are advising REV Group on the transaction
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
Qorvo $22 billion combination with Skyworks Solutions
We are advising Qorvo on the transaction
GSK exclusive license agreement with Empirico
We advised GSK on the transaction
ADC Therapeutics $60 million private placement
We advised ADC Therapeutics on the transaction involving its common shares and pre-funded warrants
NextVision Stabilized Systems NIS 1.4 billion stock offering
We advised NextVision on its global offering
New England Power $350 million senior notes offering
The investment-grade notes are due 2055
SEB $1.05 billion notes offering
The investment-grade notes are due 2030
CRH $2.5 billion guaranteed notes offering
The investment-grade notes are due 2031, 2036 and 2056
Over $44 billion of structured credit financings year to date
We advised on 119 structured credit transactions in the first three quarters of 2025